Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 10:2021:9962624.
doi: 10.1155/2021/9962624. eCollection 2021.

Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury

Affiliations
Case Reports

Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury

Phuong Chi Pham et al. Case Rep Med. .

Abstract

Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduced kidney function, or faulty measurement techniques. We herein present a case of a young pregnant woman who presented with mild acute kidney injury (AKI), invasive mucormycosis receiving liposomal amphotericin, and hyperphosphatemia out of proportion to the degree of kidney injury. While the patient was given routine phosphate-binding agent by her primary care team for presumed AKI-associated hyperphosphatemia, a full investigation by the renal consulting team for contributing factors other than kidney injury revealed that she actually had pseudohyperphosphatemia associated with the use of liposomal amphotericin. Erroneous treatment of pseudohyperphosphatemia may have been detrimental to this pregnant patient. A literature review for conditions associated with pseudohyperphosphatemia other than the use of liposomal amphotericin will be discussed.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Pham P. C. T., Deshmukh M. S., Pham P. T. T. Nephrology and Hypertension Board Review, Pham PCT and Pham PTT. Alphen aan den Rijn, Netherlands: Wolters Kluwer; 2016. Calcium, phosphorus, magnesium, and kidney stones; pp. 72–73.
    1. Mantovani G., Elli F. M. Inactivating PTH/PTHrP signaling disorders. Parathyroid Disorders. 2019;51:147–159. doi: 10.1159/000491045. - DOI - PubMed
    1. Liamis G., Liberopoulos E., Barkas F., Elisaf M. Spurious electrolyte disorders: a diagnostic challenge for clinicians. American Journal of Nephrology. 2013;38(1):50–57. doi: 10.1159/000351804. - DOI - PubMed
    1. Sawaya B. P., Briggs J. P., Schnermann J. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. Journal of the American Society of Nephrology. 1995;6(2):154–164. doi: 10.1681/asn.v62154. - DOI - PubMed
    1. Abbassi-Ghanavati M., Greer L. G., Cunningham F. G. Pregnancy and laboratory studies. Obstetrics & Gynecology. 2009;114(6):1326–1331. doi: 10.1097/aog.0b013e3181c2bde8. - DOI - PubMed

Publication types

LinkOut - more resources